Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Benign gynecological conditions among participants in the Breast Cancer Prevention Trial

Article Abstract:

A study was undertaken to report on the benign gynecologic conditions occurring among women with an intact uterus at enrolment in the Breast Cancer Prevention Trial of the National Surgical Adjuvant Breast and Bowel Project. The results supported the estrogen agonist role of tamoxifen as the causative factor for the increased risk of endometrial polyps, leiomyomas, endometriosis, and endometrial hyperplasia among women taking this agent.

Author: Wolmark, Norman, Wickerham, D. Lawrence, Chalas, Eva, Bergman, Cynthia, Contantino, Joseph, P., Runowicz, Carolyn, Lewis, George C.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2005
Care and treatment, Diagnosis, Complications and side effects, Estrogen, Tamoxifen (Medication), Familial Mediterranean fever, Periodic disease, Estrogen antagonists

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial

Article Abstract:

A study is conducted to compare the differences in patient-reported outcomes, quality of life (QOL) and symptoms in Study of Tamoxifen and Raloxifene (STAR) participants by treatment assignment. The results reveal that no significant differences existed between the tamoxifen and raloxifene groups in patient-reported outcomes for physical health, mental health and depression, although the tamoxifen group reported better sexual function.

Author: Wolmark, Norman, Wickerham, D. Lawrence, Vogel, Victor G., Ganz, Patricia A., Constantino, Joseph P., Wade, James L., III., Land, Stephanie R., Lockhart, James B., Jr., Ritter, Marcie W., Dakhil, Shaker, Lee, Myoungkeun, Pajon, Eduardo R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes

Article Abstract:

A study is conducted to compare the relative effects and safety of raloxifene and tamoxifen on the risk of developing invasive breast cancer and other disease outcomes. The results reveal that raloxifene is as effective as tamoxifen in reducing the risk of invasive breast cancer and has lower risk of thormboembolic events and cataracts but nonstatistically significant higher risk of noninvasive breast cancer.

Author: Fehrenbacher, Louis, Lippman, Scott M., Reis, Steven E., Wolmark, Norman, Wickerham, D. Lawrence, Robidoux, Andre, Ford, Leslie G., Atkins, James N., Vogel, Victor G., Ganz, Patricia A., Jordan, V. Craig, Constantino, Joseph P., Margolese, Richard G., James, Joan, Runowicz, Carolyn D., Wade, James L., III., McCaskill-Stevens, Worta, Cronin, Walter M., Pajon, Eduardo R., Jr., Cecchini, Reea S., Bevers, Therese B.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Drug therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prevention, Breast cancer, United States, Comparative analysis, Dosage and administration, Raloxifene, Tamoxifen, Clinical report
Similar abstracts:
  • Abstracts: Rosacea: A manageable condition. Diverticular disease: The importance of getting enough fiber. Anal and rectal problems: Set aside embarrassment, seek medical care
  • Abstracts: Obstetric ultrasonography: a biophysical consideration of patient safety - the "rules" have changed. Fetal cheek-to-cheek diameter in the prediction of mode of delivery
  • Abstracts: Rapidly progressive cervical cancer: the Connecticut experience. The role of ultrasound evaluation in the detection of early-stage epithelial cancer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.